Operating
Change in Other Liabilities
Moderna Change in Other Liabilities increased by 123.2% to $26.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.2%, from $33.00M to $26.00M. Over 2 years (FY 2022 to FY 2024), Change in Other Liabilities shows an upward trend with a -67.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase suggests the company is deferring obligations or increasing long-term liabilities, providing a source of cash.
Detailed definition
Captures the net change in non-current or miscellaneous liabilities not classified as debt or standard accounts payable....
Peer comparison
Commonly used to track non-operating liability fluctuations across industrial peers.
Metric ID:
change_in_other_liabilitiesHistorical Data
18 periods
| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $60.00M | $100.00M | $35.00M | $228.00M | $10.00M | -$1.01B | -$15.00M | -$3.00M | $39.00M | $67.00M | $119.00M | -$186.00M | $4.00M | $141.00M | $33.00M | -$58.00M | -$112.00M | $26.00M |
| QoQ Change | — | +66.7% | -65.0% | +551.4% | -95.6% | <-999% | +98.5% | +80.0% | >999% | +71.8% | +77.6% | -256.3% | +102.2% | >999% | -76.6% | -275.8% | -93.1% | +123.2% |
| YoY Change | — | — | — | +280.0% | — | <-999% | -142.9% | -101.3% | +290.0% | +106.6% | +893.3% | <-999% | -89.7% | +110.4% | -72.3% | +68.8% | <-999% | -21.2% |
Range-$1.01B – $228.00M
CAGR-17.9%
Avg YoY Growth-627.9%
Median YoY Growth-46.7%
Change in Other Liabilities at Other Companies
Frequently Asked Questions
- What is Moderna's change in other liabilities?
- Moderna (MRNA) reported change in other liabilities of $26.00M in Q1 2026.
- How has Moderna's change in other liabilities changed year-over-year?
- Moderna's change in other liabilities decreased by 21.2% year-over-year, from $33.00M to $26.00M.
- What is the long-term trend for Moderna's change in other liabilities?
- Over 2 years (2022 to 2024), Moderna's change in other liabilities has grown at a -67.5% compound annual growth rate (CAGR), from -$740.00M to $78.00M.
- What does change in other liabilities mean?
- The net change in miscellaneous long-term or other liabilities.